The prime function of the immune system is to protect the entire organism from a variety of insults and illnesses, including the development of cancer. The question of how age-related declines in immune function contribute to an increasing incidence of malignancies continues to be a focus of discussion and speculation.
Methods
The recent literature from the National Library of Medicine database (1990 through the present) was searched for articles using the medical subject headings (MeSH terms) of aging, immunity, cancer, senescence, and apoptosis. Bibliographies of articles retrieved were also scanned.
Results
Data from in vitro and in vivo animal and human studies demonstrate clear age-related alterations in both the cellular and humoral components of the immune system, but there is little evidence supporting direct causal links between immune senescence and most malignancies.
Conclusions
Senescent decline in immune surveillance leads to the accumulation of cellular and DNA mutations that could be a significant factor in the development of malignancy and programmed cell death or apoptosis observed in the elderly.
References
1.
SongL., KimY.H., ChopraR.K.. Age-related effects in T cell activation and proliferation.Exp Gerontol.1993; 28: 313–321.
MillerR.A.. Aging and immune function.Int Rev Cytol.1991; 124: 187–215.
4.
PhilosopheB., MillerR.A.. Diminished calcium signal generation in subsets of T lymphocytes that predominate in old mice.J Gerontol.1990; 45: B87–B93.
5.
NijhuisE.W., RemarqueE.J., HinloopenB.. Age-related increase in the fraction of CD27-CD4+ T cells and IL-4 production as a feature of CD4+ T cell differentiation in vivo.Clin Exp Immunol.1994; 96: 528–534.
6.
JackolaD.R., RugerJ.K., MillerR.A.. Age-associated changes in human T cell phenotype and function.Aging.1994; 6: 25–34.
7.
XuX., BeckmanI., AhernM.. A comprehensive analysis of peripheral blood lymphocytes in healthy aged humans by flow cytometry.Immunol Cell Biol.1993; 71: 549–557.
8.
KudlacekS., Jahandideh-KazempourS., GraningerW.. Differential expression of various T cell surface markers in young and elderly subjects.Immunobiology.1995; 192: 198–204.
9.
JackolaD.R., RugerJ.K., MillerR.A.. Age-associated changes in human T cell phenotype and function.Aging.1994; 6: 25–34.
10.
DobberR., TielemansM., NagelkerkenL.. Enrichment for Th1 cells in the Mel-14+ CD4+ T cell fraction in aged mice.Cell Immunol.1995; 162: 321–325.
11.
DobberR., TielemansM., de WeerdH.. Mel14+CD4+ T cells from aged mice display functional and phenotypic characteristics of memory cells.Int Immunol.1994; 6: 1227–1234.
12.
LeclercqG., PlumJ., NandiD.. Intrathymic differentiation of V gamma 3 T cells.J Exp Med.1993; 178: 309–315.
13.
OffnerF., KerreT., De SmedtM.. Bone marrow CD34 cells generate fewer T cells in vitro with increasing age and following chemotherapy.Br J Haematol.1999; 104: 801–808.
14.
Roberts-ThompsonI.C., WhittinghamS., Young-ChaiyudU.. Aging, immune response and mortality.Lancet.1974; 2: 368–370.
15.
MuraskoD.M., WeinerP., KayeD.. Association of lack of mitogen-induced lymphocyte proliferation with increased mortality in the elderly.Aging Immunol Infect Dis.1988; 1: 1–6.
16.
InkelesB., InnesJ.B., KuntzM.M.. Immunological studies of aging. III. Cytokinetic basis for the impaired response of lymphocytes from aged humans to plant lectins.J Exp Med.1977; 145: 1176–1187.
17.
GoodwinJ.S., MessnerR.P.. Sensitivity of lymphocytes to prostaglandin E2 increases in subjects over age 70.J Clin Invest.1979; 64: 434–439.
18.
KirschmannD.A., MuraskoD.M.. Splenic and inguinal lymph node T cells of aged mice respond differently to polyclonal and antigen-specific stimuli.Cell Immunol.1992; 139: 426–437.
19.
ErnstD.N., WeigleW.O., McQuittyD.N.. Stimulation of murine T cell subsets with anti-CD3 antibody: age-related defects in the expression of early activation molecules.J Immunol.1989; 142: 1413–1421.
20.
GarkavtsevI., HullC., RiabowolK.. Molecular aspects of the relationship between cancer and aging: tumor suppressor activity during cellular senescence.Exp Gerontol.1998; 33: 81–94.
21.
LevineA.J.. p53, the cellular gatekeeper for growth and division.Cell.1997; 88: 323–331.
22.
VanAmanS.E., WhislerR.L.. Differential expression of p53 tumor suppressor protein and IL-2 in activated T cells from elderly humans.J Interferon Cytokine Res.1998; 18: 315–320.
23.
Ohkusu-TsukadaK., TsukadaT., IsobeK.. Accelerated development and aging of the immune system in p53-deficient mice.J Immunol.1999; 163: 1966–1972.
24.
VissingaC., NagelkerkenL., ZijlstraJ.. A decreased functional capacity of CD4+T cells underlies the impaired DTH reactivity in old mice.Mech Ageing Dev.1990; 53: 127–139.
25.
GottesmanS.R.S., EdingtonJ.. Proliferative and cytotoxic immune functions in aging mice. V. Deficiency in generation of cytotoxic cells with normal lytic function per cell as demonstrated by the single cell conjugation assay.Aging Immunol Infect Dis.1990; 2: 19–29.
26.
FagioloU., AmadoriA., CozziE.. Humoral and cellular immune response to influenza virus vaccination in aged humans.Aging.1993; 5: 451–458.
27.
SwensonC.D., CherniackE.P., RussoC.. IgD-receptor up-regulation on human peripheral blood T cells in response to IgD in vitro or antigen in vivo correlates with the antibody response to influenza vaccination.Eur J Immunol.1996; 26: 340–344.
28.
McElhaneyJ.E., BeattieB.L., DevineR.. Age-related decline in interleukin 2 production in response to influenza vaccine.J Am Geriatr Soc.1990; 38: 652–658.
29.
Ben-YehudaA., EhleiterD., HuA.R.. Recombinant vaccinia virus expressing the PR/8 influenza hemagglutinin gene overcomes the impaired immune response and increased susceptibility of old mice to influenza infection.J Infect Dis.1993; 168: 352–357.
30.
RagozzinoM.W., MeltonLJIII, KurlandL.T.. Population-based study of herpes zoster and its sequelae.Medicine (Baltimore).1982; 61: 310–316.
31.
BurkeB.L., SteeleR.W., BeardO.W.. Immune responses to varicella-zoster in the aged.Arch Intern Med.1982; 142: 291–293.
32.
DonahueJ.G., ChooP.W., MansonJ.E.. The incidence of herpes zoster.Arch Intern Med.1995; 155: 1605–1609.
33.
RagozzinoM.W., MeltonLJIII, KurlandL.T.. Risk of cancer after herpes zoster: a population-based study.N Engl J Med.1982; 307: 393–397.
34.
KishimotoS., TominoS., MitsuyaH.. Age-related changes in suppressor functions of human T cells.J Immunol.1979; 123: 1586–1593.
35.
GrossmannA., LedbetterJ.A., RabinovitchP.S.. Reduced proliferation in T lymphocytes in aged humans is predominantly in the CD8+ subset and is unrelated to defects in transmembrane signaling which are predominantly in the CD4+ subsets.Exp Cell Res.1989; 180: 367–382.
36.
DoriaG., ManciniC., FrascaD.. Age restriction in antigen-specific immunosuppression.J Immunol.1987; 139: 1419–1425.
37.
RussoC., CherniakE.P., WaliA.. Age-dependent appearance of non-major histocompatibility complex-restricted helper T cells.Proc Natl Acad Sci U S A.1993; 90: 11718–11722.
38.
HaraH., NegoroS., MiyataS.. Age-associated changes in proliferative and differentiative response of human B cells and production of T cell-derived factors regulating B cell functions.Mech Ageing Dev.1987; 38: 245–258.
39.
HallgrenH.M., BuckleyCEIII, GilbertsenV.A.. Lymphocyte phytohemagglutinin responsiveness, immunoglobulins, and autoantibodies in aging humans.J Immunol.1973; 111: 1101–1107.
40.
MakinodanT.. Biology of aging: retrospect and prospect. In: MakinodanT., YunisE., eds. Immunology and Aging.New York, NY: Plenum Press;1977: 1–8.
41.
CallardR.E., BastenA., BlandenR.V.. Loss of immune competence with age may be due to a qualitative abnormality in lymphocyte membranes.Nature.1979; 281: 218–220.
42.
ZharharyD.. Age-related changes in the capability of the bone marrow to generate B cells.J Immunol.1988; 141: 1863–1869.
43.
Ben-YehudaA., SzaboP., DyallR.. Bone marrow declines as a site of B-cell precursor differentiation with age: relationship to thymus involution.Proc Natl Acad Sci U S A.1994; 91: 11988–11992.
44.
VialeA.C., ChiesJ.A., HuetzF.. VH-gene family dominance in ageing mice.Scand J Immunol.1994; 39: 184–188.
45.
DelafuenteJ.C.. Immunosenescence: clinical and pharmacologic considerations.Med Clin North Am.1985; 69: 475–486.
46.
SchwabR., RussoC., WekslerM.E.. Altered major histocompatibility complex-restricted antigen recognition by T cells from elderly humans.Eur J Immunol.1992; 22: 2989–2993.
47.
ZhaoK.S., WangY.F., GueretR.. Dysregulation of the humoral immune response in old mice.Int Immunol.1995; 7: 929–934.
48.
ArreazaE.E., GibbonsJJJr, SiskindG.W.. Lower antibody response to tetanus toxoid associated with higher auto-anti-idiotypic antibody in old compared with young humans.Clin Exp Immunol.1993; 92: 169–173.
49.
CinaderB., ThorbeckeG.J.. Aging and the immune system: report on Workshop #94 held during the 7th International Congress of Immunology; August 3, 1989: Berlin.Aging Immunol Infect Dis.1990; 2: 45–53.
50.
WhittinghamS., BuckleyJ.D., MackayI.R.. Factors influencing the secondary antibody response to flagellin in man.Clin Exp Immunol.1978; 34: 170–178.
51.
BurnsE.A., L'HommedieuG.D., Patrick-MillerL.. Effect of age, sex and depression on response to primary and secondary immunization.J Am Geriatr Soc.1993; 4: SA41.
52.
LigthartG.J., CorberandJ.X., FournierC.. Admission criteria for immunogerontological studies in man: the SENIEUR protocol.Mech Ageing Dev.1984; 28: 47–55.
53.
De GreefG.E., Van StaalduinenG.J., Van DoorninckH.. Age-related changes of the antigen-specific antibody formation in vitro and PHA-induced T-cell proliferation in individuals who met the health criteria of the SENIEUR protocol.Mech Ageing Dev.1992; 66: 1–14.
54.
KishimotoS., TominoS., MitsuyaH.. Age-related decrease in frequencies of B-cell precursors and specific helper T cells involved in the IgG anti-tetanus toxoid antibody production in humans.Clin Immunol Immunopathol.1982; 25: 1–10.
55.
BurnsE.A., LumL.G., SrigneuretM.C.. Decreased specific antibody synthesis in old adults: decreased potency of antigen-B cells with aging.Mech Ageing Dev.1990; 53: 229–241.
56.
BurnsE.A., LumL.G., L'HommedieuG.. Specific humoral immunity in the elderly: in vivo and in vitro response to vaccination.J Gerontol.1993; 48: B231–B236.
57.
RemarqueE.J., van BeekW.C., LigthartG.J.. Improvement of the immunoglobulin subclass response to influenza vaccine in elderly nursing-home residents by the use of high-dose vaccines.Vaccine.1993; 11: 649–654.
58.
EnnistD.L., JonesK.H., St. PierreR.L.. Functional analysis of the immunosenescence of the human B cell system: dissociation of normal activation and proliferation from impaired terminal differentiation into IgM immunoglobulin-secreting cells.J Immunol.1986; 136: 99–105.
59.
WhislerR.L., WilliamsJWJr, NewhouseY.G.. Human B cell proliferative responses during aging: reduced RNA synthesis and DNA replication after signal transduction by surface immunoglobulins compared to B cell antigenic determinants CD20 and CD40.Mech Ageing Dev.1991; 61: 209–222.
60.
HuA., EhleiterD., Ben-YehudaA.. Effect of age on the expressed B cell repertoire: role of B cell subsets.Int Immunol.1993; 5: 1035–1039.
61.
NicolettiC., YangX., CernyJ.. Repertoire diversity of antibody response to bacterial antigens in aged mice. III. Phosphorylcholine antibody from young and aged mice differ in structure and protective activity against infection with Streptococcus pneumoniae.J Immunol.1993; 150: 543–549.
62.
NicolettiC.. Antibody protection in aging: influence of idiotypic repertoire and antibody binding activity to a bacterial antigen.Exp Mol Pathol.1995; 62: 99–108.
63.
MillerC., KelsoeG.. Ig VH hypermutation is absent in the germinal centers of aged mice.J Immunol.1995; 155: 3377–3384.
64.
BorghesiC., NicolettiC.. Increase of cross(auto)-reactive antibodies after immunization in aged mice: a cellular and molecular study.Int J Exp Pathol.1994; 75: 123–130.
65.
DelfraissyJ.F., GalanaudP., WallonC.. Abolished in vitro antibody response in elderly: exclusive involvement of prostaglandin-induced T suppressor cells.Clin Immunol Immunopathol.1982; 24: 377–385.
66.
DelfraissyJ.F., GalanaudP., DormontJ.. Age-related impairment of the in vitro antibody response in the human.Clin Exp Immunol.1980; 39: 208–214.
67.
McLachlanJ.A., SerkinC.D., Morrey-ClarkK.M.. Immunological functions of aged human monocytes.Pathobiology.1995; 63: 148–159.
68.
DanonD., KowatchM.A., RothG.S.. Promotion of wound repair in old mice by local injection of macrophages.Proc Natl Acad Sci U S A.1989; 86: 2018–2020.
69.
Izumi-HishaH., ItoY., SugkmotoK.. Age-related decrease in the number of hemopoietic stem cells and progenitors in senescence accelerated mice.Mech Ageing Dev.1990; 56: 89–97.
70.
SzakalA.K., KapasiZ.F., MasudaA.. Follicular dendritic cells in the alternative antigen transport pathway: microenvironment, cellular events, age and retrovirus related alterations.Semin Immunol.1992; 4: 257–265.
71.
BeckmanI., DimopoulosK., XuX.N.. T cell activation in the elderly: evidence for specific deficiencies in T cell/accessory cell interactions.Mech Ageing Dev.1990; 51: 265–276.
72.
McLachlanJ.A., SerkinC.D., MorreyK.M.. Antitumoral properties of aged human monocytes.J Immunol.1995; 154: 832–843.
73.
ItohH., AboT., SugawaraS.. Age-related variation in the proportion and activity of murine liver natural killer cells and their cytotoxicity against regenerating hepatocytes.J Immunol.1988; 141: 315–323.
74.
HoS.P., KramerK.E., ErshlerW.B.. Effect of host age upon interleukin-2–mediated anti-tumor responses in a murine fibrosarcoma model.Cancer Immunol Immunother.1990; 31: 146–150.
75.
KutzaJ., KayeD., MuraskoD.M.. Basal natural killer cell activity of young versus elderly humans.J Gerontol A Biol Sci Med Sci.1995; 50A: B110–116.
76.
FacchiniA., MarianiE., MarianiA.R.. Increased number of circulating Leu11+ (CD16) large granular lymphocytes and decreased NK activity during human ageing.Clin Exp Immunol.1987; 68: 340–347.
77.
KutzaJ., GrossP., KayeD.. Natural killer cell cytotoxicity in elderly humans after influenza immunization.Clin Diagn Lab Immunol.1996; 3: 105–108.
78.
DorfmanJ.R., RauletD.H.. Acquisition of Ly 49 receptor expression by developing natural killer cells.J Exp Med.1998; 187: 609–618.
79.
KutzaJ., MuraskoD.M.. Effects of aging on natural killer cell activity and activation by interleukin-2 and IFN-alpha.Cell Immunol.1994; 155: 195–204.
80.
AuernhammerC.J., FeldmeierH., NassR.. Insulin-like growth factor I is an independent coregulatory modulator of natural killer (NK) cell activity.Endocrinology.1996; 137: 5332–5336.
81.
NusbaumN.J.. The aging/cancer connection.Am J Med Sci.1998; 315: 40–49.
82.
BaylinS.B., HermanJ.G., GraffJ.R.. Alterations in DNA methylation: a fundamental aspect of neoplasia.Adv Can Res.1998; 72: 142–196.
83.
DoriaG., FrascaD.. Genes, immunity, and senescence: looking for a link.Immunol Rev.1997; 160: 159–170.
84.
WarnerH.R.. Apoptosis: a two-edged sword in aging.Anticancer Res.1999; 19: 2837–2842.
85.
ChangB.D., WatanabeK., BroudeE.V.. Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases.Proc Natl Acad Sci U S A.2000; 97: 4291–4296.
86.
EspositoD., FassinaG., SzaboP.. Chromosomes of older humans are more prone to aminopterin-induced breakage.Proc Natl Acad Sci U S A.1989; 86: 1302–1306.
87.
AkiyamaM., ShouOL., KusunokiY.. Age and dose related alteration of in vitro mixed lymphocyte culture response of blood lymphocytes from A-bomb survivors.Radiat Res.1989; 117: 26–34.
88.
MayerP.J., LangeC.S., BradleyM.O.. Age-dependent decline in rejoining of X-ray-induced DNA double-strand breaks in normal human lymphocytes.Mutat Res.1989; 219: 95–100.
89.
MelaragnoM.I., SmithM de A.. Sister chromatid exchange and proliferation pattern in lymphocytes from newborns, elderly subjects and in premature aging syndromes.Mech Ageing Dev.1990; 54: 43–53.
90.
Fernandex-PolJ.A., DouglasM.G.. Molecular interactions of cancer and age.Hematol Oncol Clin North Am.2000; 14: 25–44.
91.
AmesB.N.. Micronutrients prevent cancer and delay aging.Toxicol Lett.1998; 102–103: 5–18.
92.
MeydaniM.. Vitamin E.Lancet.1995; 345: 170–175.
93.
MeydaniS.N., HayekM.. Vitamin E and immune response. In: ChandraR.K., ed. Proceedings of international conference on nutrition and immunity.St. John's, Newfoundland: ARTS Biomedical Publishers and Distributors; 1992: 105–128.
94.
WuD., MeydaniS.N., SastreJ.. In vitro glutathione supplementation enhances interleukin-2 production and mitogenic response of peripheral blood mononuclear cells from young and old subjects.J Nutr.1994; 124: 655–663.
95.
MeydaniS.N., MeydaniM., BlumbergJ.B.. Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects: a randomized controlled trial.Am J Clin Nutr.1990; 52: 557–563.
96.
MeydaniS.N., LekaL., LoszewskiR.. Long-term vitamin E supplementation enhances immune response in healthy elderly.FASEB J.1994; 8: A274.
97.
ChandraR.K.. Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subjects.Lancet.1992; 340: 1124–1127.
98.
NegoroS., HaraH., MiyataS.. Mechanisms of age-related decline in antigen-specific T cell proliferative response: IL-2 receptor expression and recombinant IL-2 induced proliferative response of purified Tac-positive T cells.Mech Ageing Dev.1986; 36: 223–241.
99.
VissingerC., Hertogh-HuijbregtsA., RozingJ.. Analysis of the age-related decline in alloreactivity of CD4+ and CD8+ T cells in CBA/RIJ mice.Mech Ageing Dev.1990; 51: 179–194.
100.
HaraH., TanakaT., NegoroS.. Age-related changes of expression of IL-2 receptor subunits and kinetics of IL-2 internalization in T cells after mitogenic stimulation.Mech Ageing Dev.1988; 45: 167–175.
101.
NagelJ.E., ChopraR.K., PowersD.C.. Effect of age on the human high affinity interleukin 2 receptor of phytohaemagglutinin stimulated peripheral blood lymphocytes.Clin Exp Immunol.1989; 75: 286–291.
102.
GoonewardeneI.M., MuraskoD.M.. Age associated changes in mitogen induced proliferation and cytokine production by lymphocytes of the long-lived brown Norway rat.Mech Ageing Dev.1993; 71: 199–212.
103.
AjitsuS., MirabellaS., KawanishiH.. In vivo immunologic intervention in age-related T cell defects in murine gut- associated lymphoid tissues by IL-2.Mech Ageing Dev.1990; 54: 163–183.
104.
HobbsM.V., ErnstD.N., TorbettB.E.. Cell proliferation and cytokine production by CD4+ cells from old mice.J Cell Biochem.1991; 46: 312–320.
105.
WuW., PahlavaniM., CheungH.T.. The effect of aging on the expression of interleukin 2 messenger ribonucleic acid.Cell Immunol.1986; 100: 224–231.
106.
MolteniM., Della BellaS., MascagniB.. Secretion of cytokines upon allogeneic stimulation: effect of aging.J Biol Regul Homeost Agents.1994; 8: 41–47.
107.
UdhayakumarV., SubbaraoB., SethA.. Impaired autoreactive T cell-induced T cell-T cell interaction in aged mice.Cell Immunol.1988; 116: 299–307.
108.
ThomanM.L., KeoghE.A., WeigleW.O.. Response of aged T and B cells to IL-4.Aging Immunol Infect Dis.1988/1989; 1: 245–253.
109.
LiS.P., MillerR.A.. Age-associated decline in II-4 production by murine T lymphocytes in extended culture.Cell Immunol.1993; 151: 187–195.
110.
DobberR., TielemansM., NagelkerkenL.. The in vivo effects of neutralizing antibodies against IFN-gamma, IL-4, or IL-10 on the humoral immune response in young and aged mice.Cell Immunol.1995; 160: 185–192.
111.
BurnsE.A., L'HommedieuG.D., CunningJ.L.. Effects of Inter-leukin-4 on antigen-specific antibody synthesis by lymphocytes from old and young adults.Lymphokine Cytokine Res.1994; 13: 227–231.
112.
CandoreG., Di LorenzoG., MellusoM.. gamma-Interferon, interleukin-4 and interleukin-6 in vitro production in old subjects.Autoimmunity.1993; 16: 275–280.
113.
NagelkerkenL., Hertogh-HuijbregtsA., DobberR.. Age-related changes in lymphokine production related to a decreased number of CD45RBhi CD4+ T cells.Eur J Immunol.1991; 21: 273–281.
114.
KutzaJ., MuraskoD.M.. Effects of aging on natural killer cell activity and activation by interleukin-2 and IFN-alpha.Cell Immunol.1994; 155: 195–204.
115.
KrishnarajR., BhoomaT.. Cytokine sensitivity of human NK cells during immunosenescence. 2. IL-2-induced interferon gamma secretion.Immunol Lett.1996; 50: 59–63.
116.
CarusoC., CandoreG., CignaD.. Cytokine production pathway in the elderly.Immunol Res.1996; 15: 84–90.
117.
FaistE., MarkewitzA., FuchsD.. Immunomodulatory therapy with thymopentin and indomethacin: successful restoration of interleukin-2 synthesis in patients undergoing major surgery.Ann Surg.1991; 214: 264–275.
118.
ChopraR.K., HolbrookN.J., PowersD.C.. Interleukin 2, interleukin 2 receptor, and interferon-gamma synthesis and mRNA expression in phorbol myristate acetate and calcium ionophore A23187-stimulated T cells from elderly humans.Clin Immunol Immunopathol.1989; 53: 297–308.
119.
DaynesR.A., AraneoB.A., ErshlerW.B.. Altered regulation of IL-6 production with normal aging: possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative.J Immunol.1993; 150: 5219–5230.
120.
ErshlerW.B.. Interleukin-6: a cytokine for gerontologists.J Am Geriatr Soc.1993; 41: 176–181.
121.
SothernR.B., Roitman-JohnsonB., KanabrockiE.L.. Circadian characteristics of circulating interleukin-6 in men.J Allergy Clin Immunol.1995; 95: 1029–1035.
122.
LiaoZ., CaucinoJ.A., SchnifferS.M.. Increased urinary cytokine levels in the elderly.Aging Immunol Infect Dis.1993; 4: 139–153.
123.
FosterK.D., ConnC.A., KlugerM.J.. Fever, tumor necrosis factor and interleukin-6 in young, mature and aged Fischer 344 rats.Am J Physiol.1992; 262: R211–215.
124.
ClarkJ.A., PetersonT.C.. Cytokine production and aging: overproduction of IL-8 in elderly males in response to lipopolysaccharide.Mech Ageing Dev.1994; 77: 127–139.
125.
CooperA.M., CallahanJ.E., GriffinJ.P.. Old mice are able to control low-dose aerogenic infections with Mycobacterium tuberculosis.Infect Immunol.1995; 63: 3259–3265.
126.
OrmeI.M., GriffinJ.P., RobertsA.D.. Evidence for a defective accumulation of protective T cells in old mice infected with Mycobacterium tuberculosis.Cell Immunol.1993; 147: 222–229.
127.
OrmeI.M.. Mechanisms underlying the increased susceptibility of aged mice to tuberculosis.Nutr Rev.53: S35–40.
128.
OrmeI.. Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection.J Immunol.1988; 140: 3589–3593.
129.
OrmeI.M.. The response of macrophages from old mice to Mycobacterium tuberculosis and its products.Aging Immunol Infect Dis.1993; 4: 187–195.
130.
Sakata-KanekoS., WakatsukiY., MatsunagaY.. Altered Th1/Th2 commitment in human CD4+ T cells with ageing.Clin Exp Immunol.2000; 120: 267–273.
131.
ZhangY., AcunaC.L., SwitzerK.C.. Corrective effects of interleukin-12 on age-related deficiencies in IFN-gamma production and IL-12Rbeta2 expression in virus-specific CD8+ T cells.J Interferon Cytokine Res.2000; 20: 235–245.
132.
LewisR.S., CahalanM.D.. Potassium and calcium channels in lymphocytes.Ann Rev Immunol.1995; 13: 623–653.
133.
JayaramanT., OndriasovaE., OndriasK.. The inositol 1,4,5-trisphosphate receptor is essential for T-cell receptor signaling.Proc Natl Acad Sci U S A.1995; 92: 6007–6011.
134.
ZweifachA., LewisR.S.. Mitogen-regulated Ca2+ current of T lymphocytes is activated by depletion of intracellular Ca2+ stores.Proc Natl Acad Sci U S A.1993; 90: 6295–6299.
135.
MillerR.A., PhilosopheB., GinisI.. Defective control of cytoplasmic calcium concentration in T lymphocytes from old mice.J Cell Physiol.1989; 138: 175–182.
136.
MillerR.A.. Calcium signals in T lymphocytes from old mice.Life Sci.1996; 59: 469–475.
137.
FulopTJr, BarabasG., VargaZ.. Transmembrane signaling changes with aging.Ann NY Acad Sci.1992; 673: 165–171.
138.
PhilosopheB., MillerR.A.. Calcium signals in murine T lymphocytes: preservation of response to PHA and to an anti-Ly-6 antibody.Aging Immunol Infect Dis.1990; 2: 11–18.
139.
KawanishiH., AjitsuS., MirabellaS.. Impaired humoral immune responses to mycobacterial antigen in aged murine gut-associated lymphoid tissues.Mech Ageing Dev.1990; 54: 143–161.
140.
LustyikG., O'LearyJ.J.. Aging and the mobilization of intracellular calcium by phytohemagglutinin in human T cells.J Gerontol.1989; 44: B30–B36.
141.
JackolaD.R., HallgrenH.M.. Diminished cell-cell binding by lymphocytes from healthy elderly humans: evidence for altered activation of LFA-1 function with age.J Gerontol.1995; 50: B368–77.
142.
WhislerR.L., NewhouseY.G., BagenstoseS.E.. Age-related reductions in the activation of mitogen-activated protein kinases p44mapk/ERK1 and p42mapk/ERK2 in human T cells stimulated via ligation of the T cell receptor complex.Cell Immunol.1996; 168: 201–210.
143.
WhislerR.L., NewhouseY.G., GrantsI.S.. Differential expression of the alpha- and beta-isoforms of protein kinase C in peripheral blood T and B cells from young and elderly adults.Mech Ageing Dev.1995; 77: 197–211.
144.
PatelH.R., MillerR.A.. Age-associated changes in mitogen-induced protein phosphorylation in murine T lymphocytes.Eur J Immunol.1992; 22: 253–260.
145.
ShiJ., MillerR.A.. Differential tyrosine-specific protein phosphorylation in mouse T lymphocyte subsets: effect of age.J Immunol.1993; 151: 730–739.
146.
WhislerR.L., BeiqingL., ChenM.. Age-related decreases in IL-2 production by human T cells are associated with impaired activation of nuclear transcriptional factors AP-1 and NF-AT.Cell Immunol.1996; 169: 185–195.
147.
WhislerR.L., LiuB., WuL.C.. Reduced activation of transcriptional factor AP-1 among peripheral blood T cells from elderly humans after PHA stimulation: restorative effect of phorbol diesters.Cell Immunol.1993; 152: 96–109.
148.
WhislerR.L., GrantsI.S.. Age-related alterations in the activation and expression of phosphotyrosine kinases and protein kinase C (PKC) among human B cells.Mech Ageing Dev.1993; 71: 31–46.
149.
GoodwinJ.S.. Decreased immunity and increased morbidity in the elderly.Nutr Rev.1995; 53: S41–S46.
150.
BenderB.S., NagelJ.E., AdlerW.H.. Absolute peripheral blood lymphocyte counts and subsequent mortality of elderly men. The Baltimore Longitudinal Study of Aging.J Am Geriatr Soc.1986; 34: 649–654.
151.
FergusonF.G., WikbyA., MaxsonP.. Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors.J Gerontol A Biol Sci Med Sci.1995; 50: B378–382.
WayneS., RhyneR.L., GarryP.J.. Cell-mediated immunity as a predictor of morbidity and mortality in subjects over 60.J Gerontol.1990; 45: 45–48.
154.
BurnetF.M.. The concept of immunological surveillance.Prog Exp Tumor Res.1970; 13: 1–27.
155.
ThomasL.. Reactions to homologous tissue antigens in relation to hypersensitivity. In: LawrenceH.S., ed. Cellular and Humoral Aspects of the Hypersensitivity States.New York, NY: Hoeber-Harper;1959: 529–532.
156.
GattiR.A., GoodR.A.. Aging, immunity and malignancy.Geriatics.1970; 25: 158–168.
157.
FraumeniJ.F., HooverR.N., DevesaS.S.. Epidemiology of cancer. In: DeVitaVTJr, HellmanS., RosenbergS.A., eds. Cancer: Principles and Practice of Oncology.4th ed.Philadelphia, Pa: JB Lippincott Co;1993: 150–181.
158.
NewellG.R., SpitzM.R., SiderJ.G.. Cancer and age.Semin Oncol.1989; 16: 3–9.
159.
PhillipsJ.A., MehtaK., FernandezC.. The NZB mouse as a model for chronic lymphocytic leukemia.Cancer Res.1992; 52: 437–443.
160.
ShiraiT., OkadaT., HiroseS.. Genetic regulation of CD5+ B cells in autoimmune disease and in chronic lymphocytic leukemia.Ann NY Acad Sci.1992; 651: 509–526.
161.
RavecheE., FernandesH., OngH.. Regulatory role of T cells in a murine model of lymphoproliferative disease.Cell Immunol.1998; 187: 67–75.
162.
DavidsonW.F., GieseT., FredricksonT.N.. Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions.J Exp Med.1998; 187: 1825–1838.
163.
Ohkusu-TsukadaK., TsukadaT., IsobeK.. Accelerated development and aging of the immune system in p53-deficient mice.J Immunol.1999; 163: 1966–1972.
